Fig. 7From: Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parametersOverall survival data grouping patients above or below the median for the ICOS+% of CD8+ T cells at baseline. Statistical significance calculated using Mantel Cox log rank test. Solid and dotted lines show data above and below the median values, respectivelyBack to article page